tiprankstipranks
Corcept Therapeutics Inc. (CORT)
NASDAQ:CORT
US Market

Corcept Therapeutics (CORT) Income Statement

Compare
897 Followers

Corcept Therapeutics Income Statement

Last quarter (Q4 2024), Corcept Therapeutics's total revenue was $181.89M, an increase of 34.33% from the same quarter last year. In Q4, Corcept Therapeutics's net income was $30.75M. See Corcept Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 675.04M$ 482.38M$ 401.86M$ 365.98M$ 353.87M
Gross Profit
$ 664.16M$ 475.89M$ 396.47M$ 360.70M$ 348.29M
Operating Expenses
$ 527.21M$ 368.61M$ 283.84M$ 236.22M$ 220.09M
Depreciation and Amortization
$ 0.00$ 1.04M$ 2.97M$ 3.07M$ 2.24M
EBITDA
$ 136.95M$ 108.32M$ 112.63M$ 124.48M$ 130.44M
Operating Income
$ 136.95M$ 107.28M$ 112.63M$ 124.48M$ 128.20M
Other Income/Expenses
$ 24.54M$ 17.27M$ 3.56M$ 529.00K$ 3.40M
Pretax Income
$ 161.49M$ 124.56M$ 116.19M$ 125.01M$ 131.60M
Net Income
$ 139.73M$ 106.14M$ 101.42M$ 112.51M$ 106.01M
Per Share Metrics
Basic EPS
$ 1.35$ 1.02$ 0.95$ 0.97$ 0.92
Diluted EPS
$ 1.23$ 0.94$ 0.87$ 0.89$ 0.85
Weighted Average Shares Outstanding
103.23M 103.56M 106.79M 115.65M 115.41M
Weighted Average Shares Outstanding (Diluted)
113.48M 111.74M 115.97M 125.96M 124.19M
Currency in USD

Corcept Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis